Arginine

Arginine

SCHEMBL3520968

C[C@@H](OC(=O)[C@@H](N)CCCNC(=N)N)[C@H](N)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCCCC[C@H](N)C(=O)OC(=O)[C@@H](N)COC(=O)CN.N[C@@H](CO)C(=O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL6130138 0.85 GSR (0.46) GSR
Glycine SCHEMBL7934640 0.84 GSR (0.38) GSR
SCHEMBL7142819 0.83 NPY4R (0.34)
Lysine SCHEMBL16762309 0.83 GSR (0.38) GSR
Arginine SCHEMBL10876829 0.82 GSR (0.43) GSR
Lysine SCHEMBL5579150 0.82 GSR (0.49) GSR
Arginine SCHEMBL1278143 0.82 GSR (0.49) GSR
Arginine SCHEMBL904454 0.80 OTC (0.41) GSR
Arginine SCHEMBL16762308 0.79 GSR (0.43) GSR
Serine SCHEMBL18223737 0.79 OTC (0.36) GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100322951-A1 Replication-proficient dsRNA capsids and uses thereof BACILLIGEN, INC. (US) 2010-12-23 US disclosed
WO-2008140598-A2 NOVEL IMMUNOTHERAPEUTIC MYCOBACTERIA, PHARMACEUTIC FORMULATIONS AND USES THEREOF BACILLIGEN, INC. (US) 2008-11-20 WO disclosed
WO-2008127486-A2 REPLICATION-PROFICIENT DSRNA CAPSIDS AND USES THEREOF BACILLIGEN, INC. (US) 2008-10-23 WO disclosed